Verve Therapeutics Overview
Verve Therapeutics Discounted Cash Flow
DCF Analysis for VERV.
Get informed when a big investor buys or sells
+ FollowFair Value
$-9.37
Current Fair Value
$-9.37
↓ 184.2% Downside
Overvalued by 184.2% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison